PARD6A antibody
Principal name
PARD6A antibody
Alternative names for PARD6A antibody
PAR6A, PAR-6 alpha, PAR-6A, PAR-6, PAR6C, TIP-40, Partitioning defective 6 homolog alpha, Tax interaction protein 40
Ncbi ID
9606, NP_001032358, NP_001032358.1, NM_001037281, NP_058644.1, NM_001047435, NM_016948
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Paraffin Sections (P), Immunoprecipitation (IP)
Background of PARD6A antibody
- Kit Component:
- - KN204843G1, PARD6A gRNA vector 1 in pCas-Guide vector
- KN204843G2, PARD6A gRNA vector 2 in pCas-Guide vector
- KN204843D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
PARD6A polyclonal antibody (A01), Lot # SIM4060302QCS1 Western Blot analysis of PARD6A expression in Jurkat ( Cat # L017V1 ).
Western Blot analysis of PARD6A expression in transfected 293T cell line (H00050855-T01) by PARD6A MaxPab polyclonal antibody.Lane 1: PARD6A transfected lysate(37.95 KDa).Lane 2: Non-transfected lysate.
PARD6A polyclonal antibody ( Cat # PAB6553 ) ( 10 µg/ml ) staining of paraffin embedded human pancreas. Microwaved antigen retrieval with Tris/EDTA buffer pH9, HRP-staining.
PARD6A MaxPab rabbit polyclonal antibody. Western Blot analysis of PARD6A expression in mouse kidney.
Western Blot analysis of PARD6A expression in transfected 293T cell line (H00050855-T02) by PARD6A MaxPab polyclonal antibody.Lane 1: PARD6A transfected lysate(37.30 KDa).Lane 2: Non-transfected lysate.
PARD6A MaxPab rabbit polyclonal antibody. Western Blot analysis of PARD6A expression in mouse kidney.
Immunoprecipitation of PARD6A transfected lysate using anti-PARD6A MaxPab rabbit polyclonal antibody and Protein A Magnetic Bead (U0007), and immunoblotted with PARD6A MaxPab mouse polyclonal antibody (B01) (H00050855-B01).
Human NCI-H226; WB Suggested Anti-PARD6A Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: NCI-H226 cell lysate; PARD6A antibody - N-terminal region (ARP42883_P050) in Human NCI-H226 cells using Western Blot
TA302913 (5µg/ml) staining of paraffin embedded Human Heart. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.
TA302913 (10µg/ml) staining of paraffin embedded Human Pancreas. Microwaved antigen retrieval with Tris/EDTA buffer pH9, HRP-staining.
Predicted band size: 37 kDa . Positive control: 293T cell lysate. Recommended dilution: 1/500-2000
Predicted cell location: Cytoplasm. Positive control: Human gastric cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using PARD6A antibody at dilution 1/40, on the right is treated with the synthetic peptide. (Original magnification: x200)
Predicted band size: 37 kDa . Positive control: Human fetal muscle tissue lysate. Recommended dilution: 1/500-2000
Western blot analysis of extracts of 293T cell lines, using PARD6A antibody.
Immunohistochemistry of paraffin-embedded human gastric cancer tissue using PARD6A antibody.
The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using (PARD6A Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human breast cancer tissue using (PARD6A Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
WB Suggested Anti-PARD6A Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: NCI-H226 cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA302913 | PARD6A (C-term) antibody |
||||||
| Goat Polyclonal Antibody against PARD6A | |||||||
 |
Goat | Aff - Purified | Hu | P |
0.1 mg /
$360.00
|
||
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||